Outcome Measures in Cancer Rehabilitation: Pain, Function, and Symptom Assessment

Assessment of cancer rehabilitation outcome measures is integral for patient assessment, symptom screening, and advancing scientific research. In the broad field of cancer rehabilitation, outcome measures can cross-cut across many different branches of oncologic care including clinician-reported, pa...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in pain research (Lausanne, Switzerland) Vol. 2; p. 692237
Main Authors Maldonado, Eduardo, Thalla, Nirguna, Nepaul, Sargoon, Wisotzky, Eric
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 29.09.2021
Subjects
cancer rehabilitation
function
outcome measures
pain
Pain Research
rehabilitation
pain
rehabilitation
cancer rehabilitation
outcome measures
function
Online AccessGet full text

Cover

More Information
Summary:Assessment of cancer rehabilitation outcome measures is integral for patient assessment, symptom screening, and advancing scientific research. In the broad field of cancer rehabilitation, outcome measures can cross-cut across many different branches of oncologic care including clinician-reported, patient-reported, and objective measures. Specific outcome measures that apply to cancer rehabilitation include those pertinent to pain, function, quality of life, fatigue, and cognition. These outcome measures, when used in cancer rehabilitation, can be utilized to evaluate the effectiveness of an intervention and to triage to the appropriate supportive care service. This review article summarizes some of the commonly used outcome measures that can be applied in the cancer rehabilitation setting to support scholarly work and patient care.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
This article was submitted to Cancer Pain, a section of the journal Frontiers in Pain Research
Edited by: Sara Parke, Mayo Clinic Arizona, United States
Reviewed by: So Yeon Oh, Pusan National University Yangsan Hospital, South Korea; Denis Dupoiron, Institut de Cancérologie de l'Ouest (ICO), France
ISSN:2673-561X
2673-561X
DOI:10.3389/fpain.2021.692237